These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38187821)

  • 41. Variable designs of clinical trials of neuromuscular blocking agents: an example of studies comparing rocuronium and vecuronium.
    Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Antonio-Ocampo A; Salmerón J
    Med Sci Monit; 2005 Feb; 11(2):PI22-30. PubMed ID: 15668623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants?
    Meretoja OA
    Br J Anaesth; 1989 Feb; 62(2):184-7. PubMed ID: 2564279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuromuscular block by vecuronium: simulation with a flow-volume model.
    Nigrovic V
    Eur J Anaesthesiol; 1994 Mar; 11(2):65-74. PubMed ID: 7909750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical experience of vecuronium bromide 10 mg preparation].
    Katsumata N; Shiraishi H; Suzuki H
    Masui; 1991 May; 40(5):801-6. PubMed ID: 1677050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of the aminosteroidal non-depolarizing neuromuscular blocking agent vecuronium by LC-ESI-MS: A Postmortem Investigation.
    Vorce SP; Mallak CT; Jacobs A
    J Anal Toxicol; 2008; 32(6):422-7. PubMed ID: 18652748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disposition of vecuronium bromide in the cat.
    Bencini AF; Scaf AH; Agoston S; Houwertjes MC; Kersten UW
    Br J Anaesth; 1985 Aug; 57(8):782-8. PubMed ID: 2861839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
    Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolonged Neuromuscular Blockade From Continuous Vecuronium in an Infant With Renal Failure Being Treated With Dialysis.
    O'Connell MP; Stauber SD
    J Pediatr Pharmacol Ther; 2022; 27(4):400-403. PubMed ID: 35558355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis and monitoring of hepatocellular carcinoma in Hepatitis C virus patients using attenuated total reflection Fourier transform infrared spectroscopy.
    Ali S; Naveed A; Hussain I; Qazi J
    Photodiagnosis Photodyn Ther; 2023 Sep; 43():103677. PubMed ID: 37390855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat.
    Bencini AF; Houwertjes MC; Agoston S
    Br J Anaesth; 1985 Aug; 57(8):789-95. PubMed ID: 2861840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality Variations in Thyrotropin Alfa.
    Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Samano-Garcia C; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 37396298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days.
    Johnson CE; Cober MP
    Am J Health Syst Pharm; 2007 Nov; 64(22):2356-8. PubMed ID: 17989445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Betamethasone-induced resistance to neuromuscular blockade: a comparison of atracurium and vecuronium in vitro.
    Robinson BJ; Lee E; Rees D; Purdie GL; Galletly DC
    Anesth Analg; 1992 May; 74(5):762-5. PubMed ID: 1348914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
    Ornstein E; Matteo RS; Schwartz AE; Silverberg PA; Young WL; Diaz J
    Anesthesiology; 1987 Aug; 67(2):191-6. PubMed ID: 2886081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of intraoperative magnetic resonance imaging on the neuromuscular blockade of vecuronium bromide in neurosurgery.
    Guo Y; Zhang H; Sun L
    Neurol Med Chir (Tokyo); 2013; 53(4):201-6. PubMed ID: 23615407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat.
    Sutherland GA; Squire IB; Gibb AJ; Marshall IG
    Br J Anaesth; 1983 Nov; 55(11):1119-26. PubMed ID: 6139121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.